Entero Therapeutics Inc (ENTO)
1.80
0.00 (0.00%)
USD |
NASDAQ |
Jun 26, 11:27
Entero Therapeutics Enterprise Value: 70.15M for June 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 25, 2024 | 70.15M |
| June 24, 2024 | 70.07M |
| June 21, 2024 | 70.18M |
| June 20, 2024 | 70.91M |
| June 18, 2024 | 70.55M |
| June 17, 2024 | 70.75M |
| June 14, 2024 | 70.73M |
| June 13, 2024 | 71.08M |
| June 12, 2024 | 70.73M |
| June 11, 2024 | 71.08M |
| June 10, 2024 | 71.54M |
| June 07, 2024 | 71.75M |
| June 06, 2024 | 71.96M |
| June 05, 2024 | 71.99M |
| June 04, 2024 | 72.10M |
| June 03, 2024 | 72.68M |
| May 31, 2024 | 72.46M |
| May 30, 2024 | 72.27M |
| May 29, 2024 | 72.10M |
| May 28, 2024 | 72.10M |
| May 24, 2024 | 72.10M |
| May 23, 2024 | 72.79M |
| May 22, 2024 | 73.12M |
| May 21, 2024 | 72.90M |
| May 20, 2024 | 72.87M |
| Date | Value |
|---|---|
| May 17, 2024 | 73.23M |
| May 16, 2024 | 73.17M |
| May 15, 2024 | 72.82M |
| May 14, 2024 | 73.20M |
| May 13, 2024 | 72.43M |
| May 10, 2024 | 72.09M |
| May 09, 2024 | 70.74M |
| May 08, 2024 | 70.66M |
| May 07, 2024 | 70.38M |
| May 06, 2024 | 70.30M |
| May 03, 2024 | 70.30M |
| May 02, 2024 | 70.68M |
| May 01, 2024 | 70.79M |
| April 30, 2024 | 70.38M |
| April 29, 2024 | 70.46M |
| April 26, 2024 | 70.58M |
| April 25, 2024 | 70.56M |
| April 24, 2024 | 71.15M |
| April 23, 2024 | 71.35M |
| April 22, 2024 | 70.93M |
| April 19, 2024 | 70.30M |
| April 18, 2024 | 70.79M |
| April 17, 2024 | 70.91M |
| April 16, 2024 | 71.15M |
| April 15, 2024 | 71.66M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.9703M
Minimum
Dec 18 2023
114.44M
Maximum
Mar 16 2021
21.68M
Average
14.31M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.939M |
| Palatin Technologies Inc | 19.19M |
| iBio Inc | 26.41M |
| Theriva Biologics Inc | -11.19M |
| Oragenics Inc | 4.128M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 5.568M |
| Total Expenses (Quarterly) | 9.226M |
| EPS Diluted (Quarterly) | 0.38 |
| Earnings Yield | -2.74K% |